Iradimed (IRMD) Capital Expenditures (2013 - 2026)

Iradimed (IRMD) has reported Capital Expenditures for 14 consecutive years, with $185000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 92.98% year-over-year to $185000.0 in Q2 2026; TTM through Jun 2026 was $2.0 million, a 84.38% decrease from a year earlier, with the FY2025 full-year figure at $7.8 million, down 3.0% from the prior year.
• Capital Expenditures was $185000.0 for Q2 2026 at Iradimed, down from $403000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $6.4 million in Q1 2023 and troughed at $185000.0 in Q2 2026.
• A 5-year average of $1.4 million and a median of $383120.0 in 2022 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures soared 2550.15% in 2023 and slumped 95.77% in 2024, its largest moves.
• Over 5 years, Capital Expenditures stood at $213540.0 in 2022, then jumped by 149.09% to $531903.0 in 2023, then jumped by 424.56% to $2.8 million in 2024, then plunged by 89.46% to $294174.0 in 2025, then slumped by 37.11% to $185000.0 in 2026.
• The last three Capital Expenditures figures came in at $185000.0 (Q2 2026), $403000.0 (Q1 2026), and $294174.0 (Q4 2025), per Business Quant data.